Plunkett Research Online: Aptinyx Inc

APTINYX INC (APTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a nov.....


APTINYX INC

Ticker: APTX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 847 871-0377
Fax:
Address: 909 Davis Street Suite 600
Evanston, IL 60201 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Norbert RiedelCEO/Director
Ashish KhannaCFO/Chief Accounting Officer/Other Executive Officer
See More
Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a nov.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture